Strides Arcolab ready to supply HINI drug

Drug firm Strides Acrolab on Tuesday said it is in a position to supply Oseltamivir Capsules, the only available medicine against Influenza A HINI virus (Swine Flu), to meet the demand both from domestic and overseas market.

"Strides is fully geared to meet significant supply of the product for domestic and international market," Strides Acrolab Ltd CEO India Operations said in a statement.
Oseltamivir Capsules are the generic version of Roche's patented drug 'Tamiflu'.

Strides' generic Oseltamivir is manufactured in US FDA approved manufacturing facility in Bangalore and the company has conducted necessary bioequivalence studies and established bioequivalence of its product with Tamiflu, the company said.